Keywords
progestacionales
progesterona
gestágenos
gestógenos
progestágenos
progestógenos
progestínicos
anovulatorios
progesterona
gestágenos
gestógenos
progestágenos
progestógenos
progestínicos
anovulatorios
How to Cite
López Escobar, G. (2018). Progestacionales. Revisión y Comentarios. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, -4(1), 137–163. https://doi.org/10.53853/encr.-4.1.317
Abstract
FRAGMENTO
1 DENOMINACIONES
Muchos han sido los nombres que a través de la literatura se le han dado a estos compuestos de acción un tanto similar a la de la Progesterona. Así se los ha llamado: Gestágenos, Gestógenos, Progestángenos, Progestógenos, Progestínicos, Compuestos Progestacionales, Agentes Progestacionales Anovulatorios, etc.
References
1. R. I. DORFMAN. Steroid Hormones in Gynecology Obstetrical and Gynecological Survey. 18: NO 1. p. 65, febrero 1963.
2. H. S. KUPPERMAN. Human Endocrinology. 1: p. 406, F. A, Davis Publ. Fi.
3. H. DOMINGUEZ. Clinical Evaluation of New Oral Progestin. American Journal of Obstetrics and Gyinecology. 84: p. 1478 diciembre 1962.
4. EDUARD EICHNER. Clinical Uses of 17-x-Hydroxy-6x Methylprogesterone Acetate in Gynecologyc and Obstetric Pratic. American Journal of Obstetrice and Gynecology. 86: p. 171, mayo 15, 1963.
5. N. E. BORGLIN. Inhiditory Effect of Lynestrenol and Lyndiol on Human Ovarion Function. Int. J. of Fertility. 9: p. I. 17 (January-March) 1964.
6. J. LANWERYNS, J. FERIN. Effects on The Ovary of prolonged Administration of Lynestrenol: A. Histological Study. Int. J. of Fertility 9: p. 35, (Jan. March) 1964.
7. J. FERIN et al. Ovarian Inhibition Düring Lactation. Int. J. of Fertility. 9: p. 41, (Jan-March) 1964.
8. H. BREHOM. Circulation, Blood Coagulation, and Clinical Observations Düring Hormonal Suppression of Ovulation. Int. J. of Fertility. 9: p. 45, (Jan-March) 1964.
9. H. KOPERA et al. Critical Evaluation of Clinical Data on Lyndiol. Int. J. of Fertility. 9: p. 69, (Jan-March) 1964.
10. J. NEVINNY and STICKEL. Inhibition of Ovulation Determined By Estimation of Pregnendiol Excretion. Int. J. of Fertility. 9: p. 57, (Jan-March) 1964.
11. N. C. N. JACKSON, and R. LYNN. Optimun Dossage for Estrogen Progestogen Balance to Inhibit Ovulation. Int. J. of Fertility. 9: p. 75, (Jan-March) 1964.
12. R. KAISER. The Inhibition of Ovulation With Oral Progestative Substances. Int. J. of Fertility. 9: p. 87, (Jan-March) 1964.
13. C. R. GARCIA and G. PINCUS. Ovulation Inhibition by Progestin Estrogen Combination. Int. J. of Fertility 9: p. 95, (Jan-March) 1964. 14. L. I. S. WAAB. A Field Trial With Lyndiol and Conovid. Int. J. of Fertility. 9: NO 1, p. 107, (Jan-March) 1964.
15. R. VANEK. Ovarian Inhibition With Ethynodiol-Acetato. Int. J. of Fertility 9: NO 1, p. 127, (Jan-March) 1964.
16. F. FUCHS et al. Studies on Pituitary. Adrenocoticol and Ovarian Function Düring Treatment With Medroxi Progesterone Acetate. Int. J. of Fertility.9: NO 1, p. 147, (Jan-March) 1964.
17. H. C. WALSER et al. Effects of Prolonged Administration of Progrestins on the Endometrium and the Function of the Pituitary Thyroid and Adrenal Glands. Int. J. of Fertility. 9: NO 1, p. 189, (Jan-Marcha) 1964.
18. J. ZANARTU. Effect of Synthetic oral Gestagens on Cervical mucus and Sperm Penetration. Int. J. of Fertility 9: NO 1, p. 225, (Jan-March) 1964.
19. J. BUCHOLA. The Influence of Gestagens on the Urinary Excretion of Gonadotropins. Estrogens and Pregnenediolin Women in the post-menopause and Düring the Menstrual Cycle. 9: NO 1, p. 231, (Jean-Marcha) 1964.
20. A. DUARTE et al. Progestogenos. Rev. Col. Obst. y Ginecol. 14: No 6. p. 569 diciembre 1963.
21. C. R. GARCIA y G. PINCUS. Clinical Considerations of Oral Hormonal Control of Human Fertility. Clin. Obst. and Gynec. 7: No 3, p. 844, septiembre 1964.
22. J. T. GONZALEZ-GUTIERREZ. Fibromatosis Uterina. Symposium sobre Lutoral. Syntex S. A. México.
23. R. B. GREENBLATT. Antiovulatory Drugs and Indications for their Use. Med. Clin. of N. A. 45: No 4, p. 073, julio 1961.
24. R. KELLEY et al Progestational Agents in the Treatment of Carcinoma of the Endometrium. New Eng. J. of Med. 264: p. 261, 1961.
25. A. VARGA y E. HENRIKSEN. Clinical and Histopathologic Evaluation of the 95. A. Vaf 17-ALPHA. Hydroxiprogestorone 17-N-Caproato on Endometrial Carcinoma. Obst. Gynec. 18: No 6, p. 658, diciembre 1961.
26. J. LORAINE. The Effect of Anti-Ovulatory compouds on Hormone Excretion. Int. J. of Fertility. 9: NO 1, p. 155, (Jan-March) 1964.
27. J.C. COBB et al. Oral Contraceptive Program Synchronized with Moon Phase. Fertility and Steril. 17: NP 4, p. 559, (Jul-Aug) 1966.
28. E.M. COUTINHO et al. Reversible Sterility induced by Medroxyprogesterone Injections. Fertility and Steril. 17: No. 2, p. 261, (Mar-Apr) 1966.
29. J. ZAÑARTU, Long Acting Progestagens in Fertility Control. To bepubl.
30. G. R GARCIA, Clinical Studies on Human Fertility Control. Human Fertility and Population Problems. Ed. R. O. Greep-Schenkman Pub. Co. Inc. Cambrigge Mass. 1963.
31. E G. MURRAY et al. Acción de Nor-esteroides en la Amenaza de Aborto. 31. Memorias del IV Congreso Latinoa-Americano de Obst. y Ginec. (Jul 22/62) Ed. Lerner, Bogotá.
32. G.I.M. SWYER y V. LITTLE. Absence of Hepatic Impairment in Long-term Oral Contraceptive Users. Brit. Med. J. V. I. p. 1412, (May) 1965.
33. K. E. THULIN y J. NERMARK. Seven Cases of Jaundice in Women taking an Oral Contraceptive, Anovlar. Brit. Med. J. V. I. p. 584, (March) 1966.
34. U. LARSSON y COHN. Oral Contraception and Liver-function Test. Brit. Med. J. V. I. p. 1414, (May) 1965.
35. A. EISALO et al. Liver-function Tests during Intake of Contraceptive Tablets in premenopausal Women. Brit. Med. J. V. I. p. 1416, (May) 1965.
36. J. FERIN. Les Progestatifs de Synthese comme Inhibiteurs de l'Ovulation ou de la Conception. La Contraception Masson et Cie Ed. Paris 1963.
37. E. T. TYLER. Current Status of Oral Contraception. J. A. M. A. 187: No 8, p. 562, febrero 1964.
38. C. TIETZE. Eficacia Real de los Métodos Contraceptivos. Cuarta Conf. de la Fed. Int. de Planif. de la Familia San Juan, Pto. Rico., abril 1964.
39. M. E. PANIAGUA. Progestinas Orales. Cuarta Conf. de la Fed. Int. de Planif. de la Familia. San Juan, Pto. Rico., abril 1964.
40. G. OCLANDER. Ciclos Anoculatorios mediante el tratamiento Secuencial. Semana Médica. 127: Año LXXII. NP 8.
41, E. RICE-WRAY. Ovulation Inhibition with long-acting Injectable Steroids. A preliminary report. Sexto Congreso Panamericano de Endocrinología. México, octubre 10, 1965.
2. H. S. KUPPERMAN. Human Endocrinology. 1: p. 406, F. A, Davis Publ. Fi.
3. H. DOMINGUEZ. Clinical Evaluation of New Oral Progestin. American Journal of Obstetrics and Gyinecology. 84: p. 1478 diciembre 1962.
4. EDUARD EICHNER. Clinical Uses of 17-x-Hydroxy-6x Methylprogesterone Acetate in Gynecologyc and Obstetric Pratic. American Journal of Obstetrice and Gynecology. 86: p. 171, mayo 15, 1963.
5. N. E. BORGLIN. Inhiditory Effect of Lynestrenol and Lyndiol on Human Ovarion Function. Int. J. of Fertility. 9: p. I. 17 (January-March) 1964.
6. J. LANWERYNS, J. FERIN. Effects on The Ovary of prolonged Administration of Lynestrenol: A. Histological Study. Int. J. of Fertility 9: p. 35, (Jan. March) 1964.
7. J. FERIN et al. Ovarian Inhibition Düring Lactation. Int. J. of Fertility. 9: p. 41, (Jan-March) 1964.
8. H. BREHOM. Circulation, Blood Coagulation, and Clinical Observations Düring Hormonal Suppression of Ovulation. Int. J. of Fertility. 9: p. 45, (Jan-March) 1964.
9. H. KOPERA et al. Critical Evaluation of Clinical Data on Lyndiol. Int. J. of Fertility. 9: p. 69, (Jan-March) 1964.
10. J. NEVINNY and STICKEL. Inhibition of Ovulation Determined By Estimation of Pregnendiol Excretion. Int. J. of Fertility. 9: p. 57, (Jan-March) 1964.
11. N. C. N. JACKSON, and R. LYNN. Optimun Dossage for Estrogen Progestogen Balance to Inhibit Ovulation. Int. J. of Fertility. 9: p. 75, (Jan-March) 1964.
12. R. KAISER. The Inhibition of Ovulation With Oral Progestative Substances. Int. J. of Fertility. 9: p. 87, (Jan-March) 1964.
13. C. R. GARCIA and G. PINCUS. Ovulation Inhibition by Progestin Estrogen Combination. Int. J. of Fertility 9: p. 95, (Jan-March) 1964. 14. L. I. S. WAAB. A Field Trial With Lyndiol and Conovid. Int. J. of Fertility. 9: NO 1, p. 107, (Jan-March) 1964.
15. R. VANEK. Ovarian Inhibition With Ethynodiol-Acetato. Int. J. of Fertility 9: NO 1, p. 127, (Jan-March) 1964.
16. F. FUCHS et al. Studies on Pituitary. Adrenocoticol and Ovarian Function Düring Treatment With Medroxi Progesterone Acetate. Int. J. of Fertility.9: NO 1, p. 147, (Jan-March) 1964.
17. H. C. WALSER et al. Effects of Prolonged Administration of Progrestins on the Endometrium and the Function of the Pituitary Thyroid and Adrenal Glands. Int. J. of Fertility. 9: NO 1, p. 189, (Jan-Marcha) 1964.
18. J. ZANARTU. Effect of Synthetic oral Gestagens on Cervical mucus and Sperm Penetration. Int. J. of Fertility 9: NO 1, p. 225, (Jan-March) 1964.
19. J. BUCHOLA. The Influence of Gestagens on the Urinary Excretion of Gonadotropins. Estrogens and Pregnenediolin Women in the post-menopause and Düring the Menstrual Cycle. 9: NO 1, p. 231, (Jean-Marcha) 1964.
20. A. DUARTE et al. Progestogenos. Rev. Col. Obst. y Ginecol. 14: No 6. p. 569 diciembre 1963.
21. C. R. GARCIA y G. PINCUS. Clinical Considerations of Oral Hormonal Control of Human Fertility. Clin. Obst. and Gynec. 7: No 3, p. 844, septiembre 1964.
22. J. T. GONZALEZ-GUTIERREZ. Fibromatosis Uterina. Symposium sobre Lutoral. Syntex S. A. México.
23. R. B. GREENBLATT. Antiovulatory Drugs and Indications for their Use. Med. Clin. of N. A. 45: No 4, p. 073, julio 1961.
24. R. KELLEY et al Progestational Agents in the Treatment of Carcinoma of the Endometrium. New Eng. J. of Med. 264: p. 261, 1961.
25. A. VARGA y E. HENRIKSEN. Clinical and Histopathologic Evaluation of the 95. A. Vaf 17-ALPHA. Hydroxiprogestorone 17-N-Caproato on Endometrial Carcinoma. Obst. Gynec. 18: No 6, p. 658, diciembre 1961.
26. J. LORAINE. The Effect of Anti-Ovulatory compouds on Hormone Excretion. Int. J. of Fertility. 9: NO 1, p. 155, (Jan-March) 1964.
27. J.C. COBB et al. Oral Contraceptive Program Synchronized with Moon Phase. Fertility and Steril. 17: NP 4, p. 559, (Jul-Aug) 1966.
28. E.M. COUTINHO et al. Reversible Sterility induced by Medroxyprogesterone Injections. Fertility and Steril. 17: No. 2, p. 261, (Mar-Apr) 1966.
29. J. ZAÑARTU, Long Acting Progestagens in Fertility Control. To bepubl.
30. G. R GARCIA, Clinical Studies on Human Fertility Control. Human Fertility and Population Problems. Ed. R. O. Greep-Schenkman Pub. Co. Inc. Cambrigge Mass. 1963.
31. E G. MURRAY et al. Acción de Nor-esteroides en la Amenaza de Aborto. 31. Memorias del IV Congreso Latinoa-Americano de Obst. y Ginec. (Jul 22/62) Ed. Lerner, Bogotá.
32. G.I.M. SWYER y V. LITTLE. Absence of Hepatic Impairment in Long-term Oral Contraceptive Users. Brit. Med. J. V. I. p. 1412, (May) 1965.
33. K. E. THULIN y J. NERMARK. Seven Cases of Jaundice in Women taking an Oral Contraceptive, Anovlar. Brit. Med. J. V. I. p. 584, (March) 1966.
34. U. LARSSON y COHN. Oral Contraception and Liver-function Test. Brit. Med. J. V. I. p. 1414, (May) 1965.
35. A. EISALO et al. Liver-function Tests during Intake of Contraceptive Tablets in premenopausal Women. Brit. Med. J. V. I. p. 1416, (May) 1965.
36. J. FERIN. Les Progestatifs de Synthese comme Inhibiteurs de l'Ovulation ou de la Conception. La Contraception Masson et Cie Ed. Paris 1963.
37. E. T. TYLER. Current Status of Oral Contraception. J. A. M. A. 187: No 8, p. 562, febrero 1964.
38. C. TIETZE. Eficacia Real de los Métodos Contraceptivos. Cuarta Conf. de la Fed. Int. de Planif. de la Familia San Juan, Pto. Rico., abril 1964.
39. M. E. PANIAGUA. Progestinas Orales. Cuarta Conf. de la Fed. Int. de Planif. de la Familia. San Juan, Pto. Rico., abril 1964.
40. G. OCLANDER. Ciclos Anoculatorios mediante el tratamiento Secuencial. Semana Médica. 127: Año LXXII. NP 8.
41, E. RICE-WRAY. Ovulation Inhibition with long-acting Injectable Steroids. A preliminary report. Sexto Congreso Panamericano de Endocrinología. México, octubre 10, 1965.
Authors must state that they reviewed, validated and approved the manuscript's publication. Moreover, they must sign a model release that should be sent. A copy may be reviewed here